HK1127877A1 - Composition containing peptide as the active ingredient - Google Patents
Composition containing peptide as the active ingredientInfo
- Publication number
- HK1127877A1 HK1127877A1 HK09107807.9A HK09107807A HK1127877A1 HK 1127877 A1 HK1127877 A1 HK 1127877A1 HK 09107807 A HK09107807 A HK 09107807A HK 1127877 A1 HK1127877 A1 HK 1127877A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- active ingredient
- composition containing
- containing peptide
- peptide
- composition
- Prior art date
Links
- 239000004480 active ingredient Substances 0.000 title 1
- 108090000765 processed proteins & peptides Proteins 0.000 title 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/05—Dipeptides
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
- A23L33/00—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
- A23L33/10—Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof using additives
- A23L33/17—Amino acids, peptides or proteins
- A23L33/175—Amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/011—Hydrolysed proteins; Derivatives thereof from plants
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/01—Hydrolysed proteins; Derivatives thereof
- A61K38/012—Hydrolysed proteins; Derivatives thereof from animals
- A61K38/018—Hydrolysed proteins; Derivatives thereof from animals from milk
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/02—Nutrients, e.g. vitamins, minerals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
- A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
-
- A—HUMAN NECESSITIES
- A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
- A23V—INDEXING SCHEME RELATING TO FOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES AND LACTIC OR PROPIONIC ACID BACTERIA USED IN FOODSTUFFS OR FOOD PREPARATION
- A23V2002/00—Food compositions, function of food ingredients or processes for food or foodstuffs
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Immunology (AREA)
- Epidemiology (AREA)
- Diabetes (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Nutrition Science (AREA)
- Obesity (AREA)
- Food Science & Technology (AREA)
- Mycology (AREA)
- Polymers & Plastics (AREA)
- Gastroenterology & Hepatology (AREA)
- Endocrinology (AREA)
- Emergency Medicine (AREA)
- Botany (AREA)
- Zoology (AREA)
- Coloring Foods And Improving Nutritive Qualities (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP2006117439 | 2006-04-21 | ||
PCT/JP2007/058620 WO2007123200A1 (ja) | 2006-04-21 | 2007-04-20 | ペプチドを有効成分として含有する組成物 |
Publications (1)
Publication Number | Publication Date |
---|---|
HK1127877A1 true HK1127877A1 (en) | 2009-10-09 |
Family
ID=38625100
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
HK09107807.9A HK1127877A1 (en) | 2006-04-21 | 2009-08-25 | Composition containing peptide as the active ingredient |
Country Status (8)
Country | Link |
---|---|
US (1) | US8343531B2 (ja) |
EP (1) | EP2039366A4 (ja) |
JP (2) | JP5645360B2 (ja) |
KR (1) | KR101652778B1 (ja) |
CN (1) | CN101426513B (ja) |
CA (1) | CA2649842C (ja) |
HK (1) | HK1127877A1 (ja) |
WO (1) | WO2007123200A1 (ja) |
Families Citing this family (30)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US20090202704A1 (en) * | 2008-02-13 | 2009-08-13 | Kao Corporation | Postprandial hyperglycemia-improving agent |
DE102008032828A1 (de) * | 2008-07-02 | 2010-01-07 | Technische Universität Dresden | Tryptophanhaltige Peptide aus alpha-Lactalbumin mit blutdrucksenkender und vasoprotektiver Wirkung für biofunktionelle Lebensmittel |
JP5749419B2 (ja) * | 2008-12-24 | 2015-07-15 | 雪印メグミルク株式会社 | 筋肉増強剤 |
US9523109B2 (en) * | 2011-06-24 | 2016-12-20 | Calpis Co., Ltd. | Method for enzymatically preparing peptides for use in improvement of brain function |
JP5877560B2 (ja) * | 2012-03-09 | 2016-03-08 | 森永乳業株式会社 | ジペプチジルペプチダーゼ−iv阻害剤 |
WO2014134225A2 (en) * | 2013-02-26 | 2014-09-04 | Pronutria, Inc. | Nutritive polypeptides, formulations and methods for treating disease and improving muscle health and maintenance |
US9138455B2 (en) | 2013-03-15 | 2015-09-22 | Mead Johnson Nutrition Company | Activating adiponectin by casein hydrolysate |
US9345727B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component and uses thereof |
US9352020B2 (en) | 2013-03-15 | 2016-05-31 | Mead Johnson Nutrition Company | Reducing proinflammatory response |
US9289461B2 (en) | 2013-03-15 | 2016-03-22 | Mead Johnson Nutrition Company | Reducing the risk of autoimmune disease |
US9345741B2 (en) | 2013-03-15 | 2016-05-24 | Mead Johnson Nutrition Company | Nutritional composition containing a peptide component with adiponectin simulating properties and uses thereof |
US8889633B2 (en) | 2013-03-15 | 2014-11-18 | Mead Johnson Nutrition Company | Nutritional compositions containing a peptide component with anti-inflammatory properties and uses thereof |
CN103736076B (zh) * | 2013-12-30 | 2015-03-25 | 浙江省农业科学院 | 具有降血压和降血脂双功能的二肽dl及其用途 |
CN106456633A (zh) * | 2014-06-20 | 2017-02-22 | 三得利控股株式会社 | 糖代谢改善剂 |
CN108348568B (zh) | 2015-07-16 | 2021-12-28 | 努里塔斯有限公司 | 抗炎肽及其用途 |
EP3118216A1 (en) | 2015-07-16 | 2017-01-18 | Nuritas Limited | Cellular growth and proliferation promoting peptides, and uses thereof |
EP3117831A1 (en) * | 2015-07-16 | 2017-01-18 | Nuritas Limited | Peptides for use in promoting transport of glucose into skeletal muscle |
SG11201710681XA (en) * | 2015-08-10 | 2018-01-30 | Meiji Co Ltd | Muscle synthesis-stimulating agent |
JP2018008916A (ja) * | 2016-07-15 | 2018-01-18 | 株式会社明治 | 血中アミノ酸濃度上昇促進剤 |
JP6826726B2 (ja) * | 2017-01-19 | 2021-02-10 | サラヤ株式会社 | 糖取り込み促進用経口組成物 |
JP2018123065A (ja) * | 2017-01-30 | 2018-08-09 | 株式会社明治 | インスリン分泌促進用組成物 |
ES2901134T3 (es) * | 2017-03-09 | 2022-03-21 | Evonik Operations Gmbh | Medio de cultivo que comprende oligopéptidos |
CN110381965A (zh) * | 2017-03-10 | 2019-10-25 | 株式会社明治 | 用于促进体内bdnf量增加的组合物 |
WO2019168149A1 (ja) | 2018-03-02 | 2019-09-06 | 一般財団法人糧食研究会 | 認知機能を改善するペプチド |
CN112839528A (zh) * | 2018-04-18 | 2021-05-25 | 独创成分有限合伙公司 | 用于促进肌肉生长和功能的组合物及其使用方法 |
KR20210003108A (ko) * | 2018-04-26 | 2021-01-11 | 제리아 신야쿠 고교 가부시키 가이샤 | 디펩티드 및 이것을 함유하는 의약 조성물 |
JP2020176100A (ja) * | 2019-04-22 | 2020-10-29 | 株式会社明治 | 運動誘発性筋損傷を抑制するための組成物 |
WO2021060927A1 (ko) * | 2019-09-25 | 2021-04-01 | 매일유업 주식회사 | 유청단백 가수분해물을 유효성분으로 함유하는 근감소증의 개선, 예방 또는 치료용 조성물 |
JP7475155B2 (ja) | 2020-02-14 | 2024-04-26 | 森永乳業株式会社 | 持久力向上用組成物 |
CN111855861B (zh) * | 2020-07-31 | 2021-03-19 | 西湖大学 | 伴随蛋白/肽在提高蛋白质组实验效率中的应用 |
Family Cites Families (23)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US4340592A (en) * | 1980-03-14 | 1982-07-20 | Adibi Siamak A | Nutrient compositions and method of administering the same |
JPS63165833A (ja) * | 1986-12-27 | 1988-07-09 | Canon Inc | 光学付属品 |
JPH01228918A (ja) | 1988-03-09 | 1989-09-12 | Nippon Suisan Kaisha Ltd | 抗糖尿病剤 |
DE68905387T2 (de) * | 1988-06-22 | 1993-10-21 | Ajinomoto Kk | Aminosäure-Nahrungsmittelzusammensetzungen. |
JPH03165833A (ja) * | 1989-02-28 | 1991-07-17 | Isamu Horikoshi | 新規懸濁化方法及びこの方法によって得られる組成物 |
JPH04149139A (ja) * | 1990-10-12 | 1992-05-22 | Nippon Steel Corp | 血糖降下剤 |
US20020037830A1 (en) | 1996-04-18 | 2002-03-28 | Jorn Havskov Berthelsen | Additive for use in any energy supplementation, use of a protein hydrolysate to the preparation of energy supplementation and an energy supplement containing such an additive |
JPH1084911A (ja) | 1996-07-25 | 1998-04-07 | Ota Isan:Kk | 血糖上昇抑制用食品素材 |
DE19823831A1 (de) | 1998-05-28 | 1999-12-02 | Probiodrug Ges Fuer Arzneim | Neue pharmazeutische Verwendung von Isoleucyl Thiazolidid und seinen Salzen |
GB9927603D0 (en) | 1999-11-22 | 2000-01-19 | Nestle Sa | Use of a milk protein hydrolysate in the treatment of diabetes |
DE69930464D1 (de) | 1999-12-30 | 2006-05-11 | Kerry Group Services Ltd | Aufbaupräparat, das Kohlenhydrat- und Peptidmaterial enthält und sein Gebrauch als Energieergänzung nach oder während körperlicher Übung oder als metabolischer Nährstoff für die orale Verabreichung |
BR0312537A (pt) | 2002-07-01 | 2005-04-19 | Unilever Nv | Usos de hidrolisato de proteìna de soro em composição comestìvel, método de indução da saciedade em seres humanos ou animais e método de melhoria ou controle da percepção da imagem do corpo e/ou controle do peso do corpo e/ou controle da ingestão de calorias e/ou auxìlio na adesão a um plano de dieta |
WO2004056207A1 (en) | 2002-12-20 | 2004-07-08 | Unilever N.V. | Blood glucose regulating composition |
CN100435788C (zh) | 2003-02-06 | 2008-11-26 | 株式会社大塚制药工场 | 围术期血糖值上升抑制剂 |
WO2004069236A1 (ja) | 2003-02-06 | 2004-08-19 | Otsuka Pharmaceutical Factory, Inc. | 周術期血糖値上昇抑制剤 |
JP2005289861A (ja) * | 2004-03-31 | 2005-10-20 | Meiji Seika Kaisha Ltd | グリコーゲンの貯蔵促進用の組成物 |
JP4229933B2 (ja) * | 2004-08-31 | 2009-02-25 | 株式会社マルハニチロ食品 | サケ由来アンジオテンシンi変換酵素阻害ペプチド化合物またはそれを含有するペプチド組成物とそれらの製造方法 |
JP4564330B2 (ja) | 2004-10-19 | 2010-10-20 | 住友大阪セメント株式会社 | 高強度コンクリートの初期乾燥ひび割れ防止方法 |
ES2381118T3 (es) * | 2004-12-23 | 2012-05-23 | Campina Nederland Holding B.V. | Hidrolizado de proteínas enriquecido en péptidos de inhibición de DPP-IV y su uso |
WO2006084383A1 (en) * | 2005-02-14 | 2006-08-17 | Ocean Nutrition Canada Limited | Anti-diabetic or anti-hypertensive dietary supplement |
US7846902B2 (en) * | 2005-09-20 | 2010-12-07 | Kyowa Hakko Bio Co., Ltd. | Dipeptide-comprising composition for oral administration |
CA2627566A1 (en) * | 2005-10-28 | 2007-05-10 | Nestec S.A. | Methods for the use of branched chain amino acids |
HUE026057T2 (en) * | 2006-05-09 | 2016-05-30 | Genzyme Corp | Procedures for the Treatment of Fatty Liver Disease, which comprises inhibition of glycosphingolipid synthesis |
-
2007
- 2007-04-20 US US12/226,480 patent/US8343531B2/en active Active
- 2007-04-20 EP EP07742055A patent/EP2039366A4/en not_active Withdrawn
- 2007-04-20 CA CA2649842A patent/CA2649842C/en active Active
- 2007-04-20 CN CN2007800143234A patent/CN101426513B/zh active Active
- 2007-04-20 KR KR1020087028297A patent/KR101652778B1/ko active IP Right Grant
- 2007-04-20 WO PCT/JP2007/058620 patent/WO2007123200A1/ja active Application Filing
- 2007-04-20 JP JP2008512162A patent/JP5645360B2/ja active Active
-
2009
- 2009-08-25 HK HK09107807.9A patent/HK1127877A1/xx unknown
-
2013
- 2013-02-06 JP JP2013021252A patent/JP5728512B2/ja active Active
Also Published As
Publication number | Publication date |
---|---|
EP2039366A4 (en) | 2010-01-06 |
CA2649842C (en) | 2015-02-17 |
WO2007123200A1 (ja) | 2007-11-01 |
CN101426513B (zh) | 2013-05-01 |
KR20090005202A (ko) | 2009-01-12 |
EP2039366A1 (en) | 2009-03-25 |
US20090124560A1 (en) | 2009-05-14 |
JPWO2007123200A1 (ja) | 2009-09-03 |
JP2013091668A (ja) | 2013-05-16 |
KR101652778B1 (ko) | 2016-08-31 |
CN101426513A (zh) | 2009-05-06 |
JP5645360B2 (ja) | 2014-12-24 |
CA2649842A1 (en) | 2007-11-01 |
US8343531B2 (en) | 2013-01-01 |
JP5728512B2 (ja) | 2015-06-03 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
HK1127877A1 (en) | Composition containing peptide as the active ingredient | |
IL195488A (en) | Compounds, pharmaceuticals containing them and their uses | |
EP2130552A4 (en) | PHARMACEUTICAL COMPOSITION COMPRISING AN ANTI-GRP78 ANTIBODY AS AN ACTIVE SUBSTANCE | |
EP2078731A4 (en) | PHARMACEUTICAL COMPOSITION COMPRISING ANTI-HB-EGF ANTIBODY AS ACTIVE INGREDIENT | |
ZA200709239B (en) | Compositions for administering RNAIII-inhibiting peptides | |
HK1198914A1 (en) | Novel dosage formulation | |
IL200746A0 (en) | Cyclopamine analog compounds, compositions comprising the same and uses thereof | |
ZA200607014B (en) | Insecticide composition | |
IL186336A0 (en) | Pharmaceutical composition | |
IL187748A0 (en) | Pharmaceutical compositions containing misoprostal | |
IL188352A0 (en) | Pharmaceutical compositions | |
ZA200804103B (en) | Pharmaceutical compositions | |
EP1937255A4 (en) | PHARMACEUTICAL COMPOSITION | |
EP1862184A4 (en) | PHARMACEUTICAL COMPOSITION | |
EP1904525A4 (en) | GLP-1 PHARMACEUTICAL COMPOSITIONS | |
GB0522045D0 (en) | Pharmaceutical compositions | |
IL192824A (en) | Peptide compounds, pharmaceuticals containing them and their use | |
IL192091A0 (en) | Pharmaceutical compositions | |
EP1845944A4 (en) | PHARMACEUTICAL COMPOSITIONS | |
EP1852119A4 (en) | PHARMACEUTICAL PREPARATION CONTAINING PHENOXAZINIUM DERIVATIVE AS ACTIVE INGREDIENT | |
ZA200803566B (en) | Pharmaceutical compositions | |
GB0514259D0 (en) | Pharmaceutical compositions | |
ZA200808768B (en) | Pharmaceutical composition containing the NMB0606 protein | |
ZA200803112B (en) | Pharmaceutical composition | |
GB0511801D0 (en) | Pharmaceutical composition |